Oncogene - Overexpression of the thymosin β-10 gene in human ovarian cancer cells disrupts F-actin stress fiber and leads to apoptosis. Skip to main content. Thank you for visiting nature.com.

Thymosin alpha-1 has been hypothesized to enhance the immune response to viruses and cancer cells by increasing T-cell development, antigen recognition, and activation.

An NPR investigation has identified a web of more than 30 medical practices and compounding pharmacies in over a dozen states that have made claims about thymosin alpha-1 online and on social media.

Thymosin Alpha 1 Peptide: Modulation of Cytokine Production . Findings imply that Tα1 may have an impact on the cytokine microenvironment that exists inside the immune system.

RGN-259 is a thymosin beta-4–based eye drop designed to rival Dompé’s Oxervate, the only FDA-approved prescription eye drop ...

Thymosin Alpha 1 (Tα-1), a well-established immunomodulator, is known to protect lymphocytes, reduce lymphocytopenia during radiotherapy, and enhance T lymphocytes. This study aims to evaluate the ...

Thymosin beta 4 not on WADA banned list: Stephen Dank. By Jon Pierik. Updated March 29, 2015 — 5.09pm first published at 11.50am. Save. Log in, register or subscribe to save articles for later.

Thymosin alpha-1 (TA1) is an investigational drug in Phase II trials for the treatment of chronic hepatitis B and in Phase III trials for the treatment of chronic hepatitis C. Phase II trials for ...

Thymosin a1, a synthetic polypeptide, has been demonstrated to increase the number of peripheral lymphocytes, especially T cells in patients with solid malignancies. In this current study, we aimed to ...